ArticleOncotarget2017

Synergistic suppression of t(8;21)-positive leukemia cell growth by combining oridonin and MAPK1/ERK2 inhibitors.

Pavel Spirin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.